• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项普遍的抗逆转录病毒治疗计划中,报告的艾滋病定义性疾病(ADIs)在参与者中的趋势:一项观察性研究。

Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study.

机构信息

British Columbia Centre for Excellence in HIV/AIDS, St, Paul's Hospital, Vancouver, Canada.

出版信息

AIDS Res Ther. 2011 Sep 5;8:31. doi: 10.1186/1742-6405-8-31.

DOI:10.1186/1742-6405-8-31
PMID:21892955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3180248/
Abstract

BACKGROUND

We examined trends in AIDS-defining illnesses (ADIs) among individuals receiving highly active antiretroviral therapy (HAART) in British Columbia (BC), Canada to determine whether declines in ADIs could be contributing to previously observed improvements in life-expectancy among HAART patients in BC since 1996.

METHODS

HAART-naïve individuals aged ≥ 18 years who initiated treatment in BC each of the following time-periods 1996 - 1998; 1999 - 2001; 2002 - 2004; 2005 - 2007 were included. The proportion of participants with reported ADIs were examined for each time period and trends were analyzed using the Cochran-Armitage Trend Test. Cox proportional hazards models were used to examine factors associated with ADIs.

RESULTS

A total of 3721 individuals (81% male) initiated HAART during the study period. A total of 251 reports of ADIs were received from 214 unique patients. These occurred in a median of 4 months (IQR = 1-19 months) from HAART initiation. The proportion of individuals with a reported ADI did not change significantly from 4.6% in the earliest time period to 5.8% in the latest period (p = 0.181 for test of trend). There were no significant declines in any specific ADI over the study period. Multivariable Cox models found that individuals initiating HAART during 2002-04 were at an increased risk of ADIs (AHR = 1.55; 95% CI 1.04-2.32) in comparison to 1996 - 98, but there were no significant differences in other time periods.

CONCLUSIONS

Trends in reported ADIs among individuals receiving HAART since 1996 in BC do not appear to parallel improvements in life-expectancy over the same period.

摘要

背景

我们研究了在加拿大不列颠哥伦比亚省(BC)接受高效抗逆转录病毒治疗(HAART)的个体中艾滋病定义疾病(ADIs)的趋势,以确定自 1996 年以来,BC 中 HAART 患者的预期寿命提高是否可以归因于 ADIs 的减少。

方法

纳入了在以下每个时间段内在 BC 开始治疗的年龄≥18 岁的 HAART 初治个体:1996-1998 年;1999-2001 年;2002-2004 年;2005-2007 年。每个时间段报告的 ADI 患者比例进行了检查,并使用 Cochran-Armitage 趋势检验分析了趋势。使用 Cox 比例风险模型检查了与 ADIs 相关的因素。

结果

研究期间共有 3721 人(81%为男性)开始接受 HAART。从 214 名患者中收到了 251 份 ADI 报告。这些报告发生在 HAART 开始后中位数为 4 个月(IQR=1-19 个月)。从最早的时间段的 4.6%到最新时间段的 5.8%,报告有 ADI 的个体比例没有显著变化(趋势检验 p=0.181)。在研究期间,没有任何特定的 ADI 显著减少。多变量 Cox 模型发现,与 1996-98 年相比,2002-04 年开始 HAART 的个体发生 ADIs 的风险增加(AHR=1.55;95%CI 1.04-2.32),但在其他时间段没有显著差异。

结论

自 1996 年以来,BC 中接受 HAART 的个体报告的 ADI 趋势似乎与同期预期寿命的提高不一致。

相似文献

1
Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study.在一项普遍的抗逆转录病毒治疗计划中,报告的艾滋病定义性疾病(ADIs)在参与者中的趋势:一项观察性研究。
AIDS Res Ther. 2011 Sep 5;8:31. doi: 10.1186/1742-6405-8-31.
2
Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.高效抗逆转录病毒疗法对澳大利亚个体艾滋病界定疾病发病率及生存率的影响。
J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):388-95. doi: 10.1097/00126334-200204010-00010.
3
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代艾滋病痴呆综合征的变化
AIDS. 1999 Jul 9;13(10):1249-53. doi: 10.1097/00002030-199907090-00015.
4
Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.在普遍医疗保健环境下,开始抗逆转录病毒疗法的艾滋病毒感染者中,医生的患者群体构成和死亡率。
BMJ Open. 2019 Mar 20;9(3):e023957. doi: 10.1136/bmjopen-2018-023957.
5
AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.1981 年至 2013 年加拿大不列颠哥伦比亚省艾滋病发病率和艾滋病相关死亡率:一项回顾性研究。
Lancet HIV. 2015 Mar;2(3):e92-7. doi: 10.1016/S2352-3018(15)00017-X.
6
Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.2000 - 2002年波兰的机会性感染及其他艾滋病界定疾病
Infection. 2006 Aug;34(4):196-200. doi: 10.1007/s15010-006-5030-y.
7
AIDS-defining illnesses: a comparison between before and after commencement of highly active antiretroviral therapy (HAART).
Curr HIV Res. 2007 Sep;5(5):484-9. doi: 10.2174/157016207781662425.
8
Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.加拿大不列颠哥伦比亚省CD4细胞计数≤200个/μL时高效抗逆转录病毒治疗起始率的下降以及CD4细胞计数≤200个/μL时HIV诊断的贡献。
HIV Med. 2015 Jul;16(6):337-45. doi: 10.1111/hiv.12212. Epub 2015 Feb 27.
9
Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy.在加拿大一组接受高效抗逆转录病毒治疗的HIV血清阳性个体中,慢性丙型肝炎感染与艾滋病界定疾病发生率的关系。
HIV Clin Trials. 2012 Mar-Apr;13(2):90-102. doi: 10.1310/hct1302-90.
10
Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.启动高效抗逆转录病毒疗法与艾滋病护理的连续性:监禁和出狱对依从性及艾滋病治疗结果的影响。
Antivir Ther. 2004 Oct;9(5):713-9.

引用本文的文献

1
Differences in intention to receive clinician-collected and self-collected samples for HPV DNA testing and its determinants between heterosexual males and females in Hong Kong, China: findings of a territory-wide household survey.中国香港异性恋男性和女性在接受临床医生采集与自行采集的样本进行人乳头瘤病毒(HPV)DNA检测的意愿及其决定因素方面的差异:一项全港家庭调查的结果
BMC Med. 2024 Dec 2;22(1):569. doi: 10.1186/s12916-024-03788-z.
2
Changes in Parents' COVID-19 Vaccine Hesitancy for Children Aged 3-17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys.中国国家儿童新冠疫苗接种计划推出前后3至17岁儿童家长对新冠疫苗犹豫态度的变化:重复横断面调查
Vaccines (Basel). 2022 Sep 6;10(9):1478. doi: 10.3390/vaccines10091478.

本文引用的文献

1
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.加拿大不列颠哥伦比亚省高效抗逆转录病毒治疗覆盖率、人群病毒载量与每年新增 HIV 诊断病例的关联:一项基于人群的研究。
Lancet. 2010 Aug 14;376(9740):532-9. doi: 10.1016/S0140-6736(10)60936-1. Epub 2010 Jul 16.
2
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.1994-2007 年美国患者的艾滋病定义性机会性感染疾病:一项队列研究。
AIDS. 2010 Jun 19;24(10):1549-59. doi: 10.1097/QAD.0b013e32833a3967.
3
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.与成人 HIV 感染者的非致命性 AIDS 和严重非 AIDS 事件相关的全因死亡率风险。
AIDS. 2010 Mar 13;24(5):697-706. doi: 10.1097/QAD.0b013e3283365356.
4
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.高收入国家接受联合抗逆转录病毒治疗的个体的预期寿命:14项队列研究的协作分析
Lancet. 2008 Jul 26;372(9635):293-9. doi: 10.1016/S0140-6736(08)61113-7.
5
Increase in the non-HIV-related deaths among AIDS cases in the HAART era.高效抗逆转录病毒治疗(HAART)时代艾滋病病例中与非艾滋病相关的死亡人数增加。
Curr HIV Res. 2008 Jan;6(1):77-81. doi: 10.2174/157016208783572017.
6
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.随着新型高效抗逆转录病毒疗法的出现,HIV感染者的生存率持续提高。
AIDS. 2007 Mar 30;21(6):685-92. doi: 10.1097/QAD.0b013e32802ef30c.
7
AIDS-defining opportunistic illnesses in the HAART era in New York City.纽约市高效抗逆转录病毒治疗时代的艾滋病界定机会性感染疾病。
AIDS Care. 2007 Feb;19(2):264-72. doi: 10.1080/09540120600834729.
8
CD4+ count-guided interruption of antiretroviral treatment.基于CD4细胞计数指导的抗逆转录病毒治疗中断
N Engl J Med. 2006 Nov 30;355(22):2283-96. doi: 10.1056/NEJMoa062360.
9
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.高效抗逆转录病毒治疗时代纽约市艾滋病患者的死因
Ann Intern Med. 2006 Sep 19;145(6):397-406. doi: 10.7326/0003-4819-145-6-200609190-00003.
10
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.HIV感染者的死因及死亡率比较:高效抗逆转录病毒治疗前、早期和晚期阶段的分析
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200. doi: 10.1097/01.qai.0000179459.31562.16.